APP’s bleomycin sulfate is AP-rated, preservative and latex-free, and bar-coded at the individual unit-of-use. It has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: squamous cell carcinoma, lymphomas, testicular carcinoma and malignant pleural effusion.
Caffeine citrate oral solution is indicated for the short term treatment of apnea of premature infants.